Hayden Michael R
SEC insider (Form 3/4/5 filer). CIK 0001352908. Director at AbCellera Biologics Inc. (ABCL) and 2 other issuers. 29 reported Form 4/5 transactions since Sep 2024; latest on Aug 24, 2026. Located in VANCOUVER.
Companies Hayden Michael R has filed insider reports for
- AbCellera Biologics Inc. (ABCL): Director
- IONIS PHARMACEUTICALS INC (IONS): Director
- 89bio, Inc. (ETNB): Director
Hayden Michael R
CIK: 0001352908
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (29 total)
- Aug 24, 2026ABCL
AbCellera Biologics Inc.
PurchaseIndirect53.6K shares at avg. $10.64$570K - Aug 12, 2026ABCL
AbCellera Biologics Inc.
PurchaseIndirect46.4K shares at avg. $10.37$481K - Aug 11, 2026ABCL
AbCellera Biologics Inc.
GiftIndirect50K shares- - Jul 31, 2026IONS
IONIS PHARMACEUTICALS INC
PurchaseIndirect5K shares at avg. $51.60$258K - Jul 30, 2026IONS
IONIS PHARMACEUTICALS INC
PurchaseIndirect15K shares at avg. $53.38$801K - Jul 1, 2026IONS
IONIS PHARMACEUTICALS INC
AwardDirectNon-Qualified Stock Option (right to buy)
5.4K shares- - Jul 1, 2026IONS
IONIS PHARMACEUTICALS INC
AwardDirectRestricted Stock Unit
2.3K shares- - Jun 11, 2026ABCL
AbCellera Biologics Inc.
AwardDirectShare option (right to buy)
111.7K shares- - Oct 30, 2025ETNB
89bio, Inc.
Tender OfferIndirect61.5K shares- - Oct 30, 2025ETNB
89bio, Inc.
Tender OfferDirect80.9K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 24, 2026 |  ABCL AbCellera Biologics Inc. | Purchase | 53,613 | $10.64 | $570,442 | Indirect |
| Aug 12, 2026 | ABCL AbCellera Biologics Inc. | Purchase | 46,387 | $10.37 | $481,033 | Indirect |
| Aug 11, 2026 | ABCL AbCellera Biologics Inc. | Gift | 50,000 | - | $0 | Indirect |
| Jul 31, 2026 |  IONS IONIS PHARMACEUTICALS INC | Purchase | 5,000 | $51.60 | $258,000 | Indirect |
| Jul 30, 2026 | IONS IONIS PHARMACEUTICALS INC | Purchase | 15,000 | $53.38 | $800,700 | Indirect |
| Jul 1, 2026 | IONS IONIS PHARMACEUTICALS INC | Award Non-Qualified Stock Option (right to buy) | 5,369 | - | - | Direct |
| Jul 1, 2026 | IONS IONIS PHARMACEUTICALS INC | Award Restricted Stock Unit | 2,301 | - | - | Direct |
| Jun 11, 2026 | ABCL AbCellera Biologics Inc. | Award Share option (right to buy) | 111,701 | - | - | Direct |
| Oct 30, 2025 |  ETNB 89bio, Inc. | Tender Offer | 61,538 | - | - | Indirect |
| Oct 30, 2025 | ETNB 89bio, Inc. | Tender Offer | 80,904 | - | - | Direct |
1-10 of 29 transactions